Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2844 (LINC02844) is an intergenic long non-coding RNA (lincRNA). LincRNAs belong to a subclass of long non-coding RNAs that are longer than 200 nucleotides and do not overlap with protein-coding genes[5][7]. LINC02844 is encoded in the human genome (NCBI Gene ID: 105375679, Ensembl: ENSG00000253679)[3]. As with most lincRNAs, the molecular and biological functions of LINC02844 remain uncharacterized in the current literature and major biological databases. There are no reported roles for LINC02844 as a therapeutic target or as a biomarker, and no interacting drugs or direct disease associations are documented as of now[1][3]. Note: While the general class of lincRNAs may participate in gene regulation, epigenetic processes, and diverse cellular functions, individual lincRNAs like LINC02844 often lack specific functional or clinical annotation unless detailed studies are available. This distinguishes LINC02844 from well-studied lincRNAs associated with disease or therapeutic targeting.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2844 (LINC02844).